| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V129362 | ARC19499 sodium | ARC19499 sodium is an aptamer that inhibits tissue factor pathway inhibitors (TFPIs), thereby promoting the initiation and propagation of the extrinsic coagulation pathway. | |
|
V73150 | Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) | 65147-06-0 | Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) is an activating factor X (FXa)-specific fluorescent peptide substrate for the determination of factor VIII. |
|
V115300 | DX-9065a free base | 150612-55-8 | DX-9065a free base is a selective, non-peptide, orally effective factor Xa (FXa) inhibitor with a Ki value of 41 nM for human FXa. |
|
V73141 | FXa-IN-1 | 441328-10-5 | FXa-IN-1 is an FXa inhibitor (IC50= 3 nM, Ki: 0.7 nM) with considerable oral bioavailability (F) and half-life (in vivo). |
|
V147311 | Zemocimig | 2955620-21-8 | Zemocimig is a human IgG4κ monoclonal antibody against coagulation factor F9. |
|
V2615 | Edoxaban | 480449-70-5 | Edoxaban (alsoknown as DU-176b; DU176; Lixiana; Savaysa)is a potent, direct-acting, selective, orally bioavailable factor Xa inhibitor used as ananticoagulant drug. |
|
V0948 | Rivaroxaban (BAY 59-7939) | 366789-02-8 | Rivaroxaban (BAY59-7939; BAY-59-7939;trade name: Xarelto),an approved anticoagulant drug used to treat and prevent blood clots, is the first orally bioavailable, selective anddirect inhibitor of Factor Xa with potential anti-coagulant activity. |
|
V4340 | R-ENANTIOMER OF RIVAROXABAN | 865479-71-6 | 5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban (also known as BAY 59-7939) which is the first orally available,direct inhibitor of Factor Xa with Ki and IC50 of 0.4 nM and 0.7 nM in cell-free assays, respectively. |
|
V0950 | Edoxaban tosylate monohydrate (DU-176b) | 1229194-11-9 | Edoxaban tosylate monohydrate(DU-176b;DU-176; trade name Lixiana), the tosylate salt of edoxaban which is a marketed anticoagulant drug,is a potent, selective, orally bioavailable anddirect factor Xa inhibitor with potential anti-coagulant activity. |
|
V0949 | Apixaban (BMS-56224701) | 503612-47-3 | Apixaban (formerlyBMS56224701; BMS 56224701;BMS-56224701; trade name: Eliquis),an approved drug used to treat and prevent the formation of blood clots, is a highly selective, reversible, direct inhibitor of Factor Xa with potential anti-coagulant activity. |